West Pharmaceutical Services, Inc.
WST
$263.51
-$15.59-5.59%
NYSE
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | 18.42% | -22.12% | -5.04% | -15.69% | -28.24% |
| Total Depreciation and Amortization | 6.43% | 12.36% | 13.37% | 12.61% | 14.08% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 1,042.86% | -126.32% | -110.69% | -51.81% | -86.79% |
| Change in Net Operating Assets | -129.08% | 100.29% | -12.64% | -100.40% | 155.73% |
| Cash from Operations | 7.33% | 9.48% | -20.49% | -21.73% | -2.48% |
| Capital Expenditure | 24.95% | 21.30% | 3.50% | 15.14% | -32.89% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | 200.00% | -900.00% | 85.07% |
| Cash from Investing | 25.69% | 21.30% | 3.68% | 14.21% | -23.26% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | 99.49% | 71.43% | 85.71% | -22,100.00% | -11,560.00% |
| Issuance of Common Stock | -23.53% | -73.81% | 0.00% | -70.59% | -44.26% |
| Repurchase of Common Stock | 99.73% | 50.07% | 69.17% | -86.48% | -7.34% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -3.42% | -3.40% | -3.38% | -3.57% | -3.55% |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 93.17% | 45.76% | 63.64% | -188.79% | -23.47% |
| Foreign Exchange rate Adjustments | 1,781.82% | 197.70% | -256.55% | 213.27% | -266.67% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 167.80% | 68.11% | 85.91% | -56.30% | -72.89% |